These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11219190)
1. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Kwak B; Mulhaupt F; Veillard N; Pelli G; Mach F Swiss Med Wkly; 2001 Jan; 131(3-4):41-6. PubMed ID: 11219190 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Sadeghi MM; Tiglio A; Sadigh K; O'Donnell L; Collinge M; Pardi R; Bender JR Transplantation; 2001 May; 71(9):1262-8. PubMed ID: 11397960 [TBL] [Abstract][Full Text] [Related]
3. The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins. Lee SJ; Qin H; Benveniste EN Eur J Immunol; 2008 Aug; 38(8):2325-36. PubMed ID: 18601229 [TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Butticè G; Miller J; Wang L; Smith BD Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692 [TBL] [Abstract][Full Text] [Related]
5. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221 [TBL] [Abstract][Full Text] [Related]
6. Statins as a newly recognized type of immunomodulator. Kwak B; Mulhaupt F; Myit S; Mach F Nat Med; 2000 Dec; 6(12):1399-402. PubMed ID: 11100127 [TBL] [Abstract][Full Text] [Related]
7. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W; Tang LP; Dong Y; Benveniste EN J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712 [TBL] [Abstract][Full Text] [Related]
8. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940 [TBL] [Abstract][Full Text] [Related]
9. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280 [TBL] [Abstract][Full Text] [Related]
10. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha. Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975 [TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. Montani V; Taniguchi SI; Shong M; Suzuki K; Ohmori M; Giuliani C; Napolitano G; Saji M; Fiorentino B; Reimold AM; Ting JP; Kohn LD; Singer DS Endocrinology; 1998 Jan; 139(1):280-9. PubMed ID: 9421426 [TBL] [Abstract][Full Text] [Related]
12. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression. Zika E; Fauquier L; Vandel L; Ting JP Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053 [TBL] [Abstract][Full Text] [Related]
13. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283 [TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Zika E; Greer SF; Zhu XS; Ting JP Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive effects of statins. Mach F Atheroscler Suppl; 2002 May; 3(1):17-20. PubMed ID: 12044581 [TBL] [Abstract][Full Text] [Related]
17. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain. Yun S; Gustafsson K; Fabre JW Transplantation; 1998 Jul; 66(1):103-11. PubMed ID: 9679829 [TBL] [Abstract][Full Text] [Related]
18. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts. Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124 [TBL] [Abstract][Full Text] [Related]
19. IFN-gamma inducibility of class II transactivator is specifically lacking in human tumour lines: relevance to retinoblastoma protein rescue of IFN-gamma inducibility of the HLA class II genes. Lu Y; Tschickardt ME; Schmidt BJ; Blanck G Immunol Cell Biol; 1997 Aug; 75(4):325-32. PubMed ID: 9315472 [TBL] [Abstract][Full Text] [Related]
20. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes. Dong Y; Rohn WM; Benveniste EN J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]